QUINTILES TRANSNAT (QTS BE) stock market data APIs
€144.4825
2.34(1.6%)
as of March 18, 2026
Try our APIs with
free plan!
QUINTILES TRANSNAT Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for QTS.BE.
Prev. Close
144.4825
Open
146.8202
High
148.5408
Low
144.3608
52 wk Range
120.5-199.75
Market Cap
45 727 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get QUINTILES TRANSNAT data using free add-ons & libraries
Get QUINTILES TRANSNAT Fundamental Data
QUINTILES TRANSNAT Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
QUINTILES TRANSNAT News
New
IQVIA Acquisition Expands Drug Discovery Role And Highlights Valuation Gap
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. IQVIA Holdings (NYSE:IQV) agreed to acquire discovery services assets from Charles River La...
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities
RESEARCH TRIANGLE PARK, N.C., February 25, 2026--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research...
IQVIA Holdings Inc. (IQV) Offers Impressive Upside Despite AI-Linked Threats
IQVIA Holdings Inc. (NYSE:IQV) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 19, Jailendra Singh from Truist Financial reiterated his Buy rating for IQVIA Ho...
Morgan Stanley Lowers its Price Target on IQVIA Holdings Inc. (IQV) to $240 but Maintains an Overweight Rating
IQVIA Holdings Inc. (NYSE:IQV) is among the 10 Best Consensus Buy-Rated Stocks to Invest in. On February 11, 2026, Morgan Stanley lowered its price target on IQVIA Holdings Inc. (NYSE:IQV) to $240 fro...
Get QUINTILES TRANSNAT fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
